Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

McClellan’s Policy Clout Creates Big Shoes To Fill At FDA

Executive Summary

The planned reorganization of FDA following Commissioner Mark McClellan's departure reflects an emphasis on interactions with Capitol Hill and the Administration

You may also be interested in...



FDA Economist Lutter To Head Policy & Planning Office After Hubbard Retires

FDA is announcing a leadership succession plan for the Office of Policy & Planning ahead of the impending retirement of Associate Commissioner William Hubbard

FDA adds legislative staffer

House Commerce Committee staffer Patrick Ronan is joining FDA as assistant commissioner for legislation. He will report to Associate Commissioner for Legislation Amit Sachdev, who is serving as acting deputy commissioner for policy. Sachdev is playing an increased role in policy coordination with Capitol Hill and the Administration following former FDA Commissioner McClellan's departure to CMS (1"The Pink Sheet" March 15, 2004, p. 8). Before joining the Commerce Committee at the beginning of 2003, Ronan was director of government relations for the Biotechnology Industry Organization...

FDA adds legislative staffer

House Commerce Committee staffer Patrick Ronan is joining FDA as assistant commissioner for legislation. He will report to Associate Commissioner for Legislation Amit Sachdev, who is serving as acting deputy commissioner for policy. Sachdev is playing an increased role in policy coordination with Capitol Hill and the Administration following former FDA Commissioner McClellan's departure to CMS (1"The Pink Sheet" March 15, 2004, p. 8). Before joining the Commerce Committee at the beginning of 2003, Ronan was director of government relations for the Biotechnology Industry Organization...

Related Content

UsernamePublicRestriction

Register

SC142962

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel